Copyright: ©Author(s) 2026.
World J Clin Oncol. May 24, 2026; 17(5): 119615
Published online May 24, 2026. doi: 10.5306/wjco.v17.i5.119615
Published online May 24, 2026. doi: 10.5306/wjco.v17.i5.119615
Figure 2 Serial 131I whole-body scintigraphy following three courses of radioiodine therapy.
A: Initial post-therapeutic imaging revealed cervical thyroid remnants and scattered radioactive iodine uptake in both lungs; B: Subsequent scans after the second dose demonstrated persistent neck uptake, along with a more extensive, diffuse distribution in the pulmonary regions; C: By the third cycle, no significant thyroid tissue was visible in the neck, and pulmonary foci had diminished, although an active left subclavian lymph node remained.
- Citation: Zhou CY, Ren XY, Li HH, Pan XM, Lan X, Duan D. Anlotinib plus albumin-bound paclitaxel induction-maintenance for sorafenib-refractory radioiodine-refractory differentiated thyroid cancer: A case report and review of literature. World J Clin Oncol 2026; 17(5): 119615
- URL: https://www.wjgnet.com/2218-4333/full/v17/i5/119615.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i5.119615